Plovamer - Merck Serono
Alternative Names: CO-14; PI-2301; Plovamer acetate - Merck SeronoLatest Information Update: 05 Nov 2023
At a glance
- Originator Harvard University; Peptimmune
- Developer EMD Serono; Peptimmune
- Class Amino acids; Anti-inflammatories; Antirheumatics; Peptides
- Mechanism of Action Major histocompatibility complex modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Crohn's disease; Multiple sclerosis; Rheumatoid arthritis; Uveitis